Semi-interpenetrating network of poly(ethylene glycol) and poly(D,L-lactide) for the controlled delivery of protein drugs

Journal of Biomaterials Science, Polymer Edition

Volumn 16, Issue 2, 2005, Pages 189-201

  Brown, Chad D ^a   Stayton, Patrick S ^a   Hoffman, Allan S ^a  

^a University of Washington   (United States)

Author keywords

Interpenetrating networks; Microparticles; Protein drugs; Tissue engineering

Indexed keywords

BIOCOMPATIBILITY; CONTROLLED DRUG DELIVERY; DEGRADATION; GROWTH KINETICS; HYDROGELS; ORGANIC ACIDS; ORGANIC SOLVENTS; PARTICLES (PARTICULATE MATTER); POLYETHYLENE GLYCOLS; PROTEINS; SWELLING; TISSUE;

MICROPARTICLES; POLYLACTIDE; PROTEIN DRUGS; RESULTANT PROTEIN RELEASE KINETICS; SEMI-INTERPENETRATING NETWORK; TISSUE ENGINEERING;

INTERPENETRATING POLYMER NETWORKS;

BENZYL ALCOHOL; BENZYL BENZOATE; BOVINE SERUM ALBUMIN; DRUG CARRIER; ETHYLENE GLYCOL DIMETHACRYLATE; GROWTH FACTOR; MACROGOL; POLYGLACTIN; POLYMER; SOLVENT;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; HYDROGEL; INTERPENETRATING NETWORK; METHODOLOGY; PHOTOCHEMISTRY; PRIORITY JOURNAL; TISSUE ENGINEERING;

ACRYLATES; ANIMALS; CATTLE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; MICROSPHERES; POLYESTERS; POLYETHYLENE GLYCOLS; PROTEINS; SERUM ALBUMIN, BOVINE;

BOVINAE;

EID: 23844452076     PISSN: 09205063     EISSN: None     Source Type: Journal    
DOI: 10.1163/1568562053115471     Document Type: Article

References (24)

1. J. L. Cleland, A. Daugherty and R. Mrsny, Curr. Opin. Biotechnol. 12, 212 (2001).
2. Y. Tabata, Pharm. Sci. Technol. Today 3, 80 (2000).
3. M. J. Whitaker, R. A. Quirk, S. M. Howdle and K. M. Shakesheff, J. Pharm. Pharmacol. 53, 1427 (2001).
4. J. E. Babensee, L. B. McIntire and A. G. Mikos, Pharm. Res. 17, 497 (2000).
5. S. P. Baldwin and W. M. Saltzman, Adv. Drug Deliv. Rev. 33, 71 (1998).
6. W. L. Murphy and D. J. Mooney, J. Periodont. Res. 34, 413 (1999).
7. T. P. Richardson,W. L. Murphy and D. J.Mooney, Crit. Rev. Eukaryot. Gene Expr. 11, 47 (2001).
8. C. E. Krewson and M. W. Saltzman, Brain Res. 727, 169 (1996).
9. R. Baker, Controlled Release of Biologically Active Agents. Wiley, New York, NY (1987).
10. G. Zhu, S. R. Mallery and S. P. Schwendeman, Nature Biotechnol. 18, 52 (2000).
11. I. Molina, S. Li, M. B. Martinez and M. Vert, Biomaterials 22, 363 (2001).
12. J. Street, M. Bao, L. deGuzman, S. Bunting and F. V. Peale, Jr., Proc. Natl. Acad. Sci. USA 99, 9656 (2002).
13. F. W. Okumu, et al., in: 27th International Meeting of the Controlled Release Society. Paris (2000).
14. F. W. Okumu, et al., in: Millennial World Congress of Pharmaceutical Sciences. San Francisco, CA (2000).
15. W. R. Gombotz, M. S. Healy and L. R. Brown, US Patent No. 5,019,400 (1991).
16. H. J. Lee, G. Riley, O. Johnson, J. L. Cleland, N. Kim, M. Charnis, L. Bailey, E. Duenas, A. Shahzamani, M. Marian, A. J. S. Jones and S. D. Putney, J. Pharmacol. Exp. Ther. 281, 1431 (1997).
17. O. L. Johnson, J. L. Cleland, H. J. Lee, M. Charnis, E. Duenas, W. Jaworowicz, D. Shepard, A. Shahzamani, A. J. S. Jones and S. D. Putney, Nature Med. 2, 795 (1996).
18. M. A. Tracy, Biotechnol. Prog. 14, 108 (1998).
19. K. A. Smeds, A. Pfister-Serres, D. L. Hatchell and M. W. Grinstaff, Pure Appl. Chem. A36, 981 (1999).
20. K. A. Smeds and M. W. Grinstaff, J. Biomed. Mater. Res. 54, 115 (2001).
21. S. Bryant and K. S. Anseth, J. Biomed. Mater. Res. 59, 63 (2002).
22. D. L. Elbert and J. A. Hubbell, Biomacromolecules 2, 430 (2001).
23. A. Copinet, C. Bertrand, S. Govindin, V. Coma and Y. Couturier, Chemosphere 55, 763 (2004).
24. C. Fischbach, J. Tessmar, A. Lucke, E. Schnell, G. Schmeer, T. Blunk and A. Göpferich, Surf. Sci. 491, 333 (2001).